Metabolic and Endocrine Effects of Bariatric Surgery
Metabolism Study
Sponsor: NIH
Enrolling: Male and Female Patients
Study Length: 1 Years
Clinic Visits: 3
IRB Number: AAAR3662
U.S. Govt. ID: NCT03371368
Contact: Sarah Borden: 212-305-4006 /
Additional Study Information: The purpose of these studies is to gain an understanding of the mechanisms that promote weight loss and improved glucose control. The ultimate goal is to identify therapeutic pathways for obesity and diabetes as a way to optimize surgical procedures and discover novel non-surgical targets for safe and effective drug therapy. Participants with obesity will undergo weight loss by a low-calorie diet for 12 weeks or bariatric surgery. Treatment is not randomized but includes individuals who volunteer for the diet or those who are scheduled to undergo surgery. There will also be comparison with a lean control groups. Participants will undergo testing with administration of a test meal and blood draws. Testing will occur before weight loss, at 15% weight loss, and at one year.
This study is closed
Judith Korner, MD
Do You Qualify?
Are you between ages of 18 and 65? Yes No
Do you have diabetes? (If you have pre-diabetes, please answer No.) Yes No
Do you have history of previous bariatric surgery? Yes No
Do you have obesity? Yes No
Do you live in the New York City tristate area (NY, NJ, CT)? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Sarah Borden